thiazoles has been researched along with AIDS Dementia Complex in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Brew, BJ; Cysique, LA; Howdle, GC; Johnson, K; Kassem, MS; Quidé, Y; Rae, CD | 1 |
Crews, LA; Gonzales, T; Kouznetsova, VL; Masliah, E; Overk, CR; Patrick, C; Paulino, A; Price, D; Rockenstein, E; Stocking, E; Tsigelny, IF; Wrasidlo, W | 1 |
Achim, CL; Chana, G; Everall, IP; Grant, I; Hult, BJ; Lucero, GR; Masliah, E; Nguyen, TB; Tatro, ET | 1 |
Dykstra, H; Fan, S; Mercer, AJ; Papugani, A; Persidsky, Y; Ramirez, SH; Reichenbach, N; Tuma, RF; Zhang, M | 1 |
Borowska-Lehman, J; Gross, M; Izycka-Swieszewska, E; Rzepko, R; Zółtowska, A | 1 |
5 other study(ies) available for thiazoles and AIDS Dementia Complex
Article | Year |
---|---|
Brain amyloid in virally suppressed HIV-associated neurocognitive disorder.
Topics: Aged; AIDS Dementia Complex; Alzheimer Disease; Amyloid; Aniline Compounds; Cognitive Dysfunction; Cohort Studies; Female; Humans; Male; Middle Aged; Positron-Emission Tomography; Thiazoles | 2020 |
Neuroprotective effects of the anti-cancer drug sunitinib in models of HIV neurotoxicity suggests potential for the treatment of neurodegenerative disorders.
Topics: AIDS Dementia Complex; Animals; Antineoplastic Agents; Cyclin-Dependent Kinase 5; Dasatinib; Erlotinib Hydrochloride; Flavonoids; HIV Envelope Protein gp120; In Vitro Techniques; Indoles; Lapatinib; Mice; Mice, Transgenic; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Protein Kinase Inhibitors; Purines; Pyrimidines; Pyrroles; Quinazolines; Rats; Roscovitine; Sunitinib; Thiazoles | 2014 |
Glycogen synthase kinase-3beta (GSK-3beta) inhibitors AR-A014418 and B6B3O prevent human immunodeficiency virus-mediated neurotoxicity in primary human neurons.
Topics: AIDS Dementia Complex; Caspase 3; Caspase 7; Cells, Cultured; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Indoles; L-Lactate Dehydrogenase; Macrophages; Necrosis; Nerve Degeneration; Neurons; Oximes; Thiazoles; Urea | 2009 |
Inhibition of glycogen synthase kinase 3beta (GSK3beta) decreases inflammatory responses in brain endothelial cells.
Topics: AIDS Dementia Complex; Animals; Blood-Brain Barrier; Brain; Case-Control Studies; Cell Adhesion; Cells, Cultured; Drug Evaluation, Preclinical; Encephalitis; Endothelial Cells; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Inflammation Mediators; Male; Mice; Mice, Inbred C57BL; Monocytes; Protein Kinase Inhibitors; Thiadiazoles; Thiazoles; Urea | 2010 |
Vasculopathy and amyloid beta reactivity in brains of patients with acquired immune deficiency (AIDS).
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS Dementia Complex; AIDS-Related Opportunistic Infections; Amyloid beta-Peptides; Axons; Benzothiazoles; Brain; Brain Chemistry; Brain Neoplasms; Cerebral Arteries; Cerebral Veins; Cerebrovascular Circulation; Coloring Agents; Congo Red; Female; Humans; Leukoencephalopathy, Progressive Multifocal; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Male; Meningitis, Cryptococcal; Middle Aged; Plaque, Amyloid; Thiazoles; Toxoplasmosis, Cerebral; Ubiquitin; Vasculitis | 2000 |